That distinction gets more interesting viewed through GLP-1.
Most of the conversation has focused on how much less people are eating, and the numbers justify it. Cornell research tracking 150,000 households found grocery spending fell 5.3% within six months of a household member starting a GLP-1, with savory snacks down 10.1%. What interests me is how users describe the experience. Foods they once enjoyed suddenly feel too sweet, too rich, too heavy, or simply not worth finishing.
I don't see GLP-1 as an appetite story. I see it as a formulation story.
After years of working on flavor systems, that's the read I keep coming back to. Howard Moskowitz's work on the "bliss point" helped define how food companies optimize sweetness, saltiness, richness and overall palatability. Entire categories were built around finding that point.
GLP-1 changes the conditions under which consumers experience those products. Companies invested billions optimizing foods for a predictable sensory response. When foods that once tasted balanced suddenly feel like too much, the product is no longer delivering the experience it was designed to deliver.
That's why I think the industry is drawing the wrong conclusion. The immediate response has been to add protein, launch GLP-1 product lines or shrink portions. Those are easy levers to pull. What I see is a reformulation opportunity.
Consider a brand that responds to slowing category growth by launching a higher-protein version of an existing product. The launch may earn distribution, trial and a stronger nutrition story. But if repeat purchase weakens because the product is still too sweet, too rich or too heavy, the business has solved the wrong problem. The result is another SKU, another innovation cycle and another claim competing for attention. Meanwhile, the original product sits untouched.
Renting demand
Borrowing interest from a trend instead of earning it with the product. When the trend moves on, the demand goes with it.
The obvious objection is that GLP-1 users are still a minority, so why touch the core? Because they're no longer a small one. Numerator's tracking now puts a current user in 22% of American households, and a household shares one pantry. The research also shows something the line-extension strategy misses: about a third of users stop the medication, and their spending drifts back. A GLP-1 product line chases a customer who comes and goes. A better core product keeps the household either way.
If my team and I were at the bench, we wouldn't start by asking how much protein to add. We'd start by re-establishing the sensory target: testing lower sweetness curves, lower flavor intensity, different fat delivery systems, and texture and viscosity changes that support satiety, along with the role fiber can play in fullness, digestive comfort and regularity. The question would be whether the product delivers satisfaction sooner and more efficiently than it did before. And we'd prove it before betting the brand on it, with a regional test measured on repeat purchase rather than trial.
Many companies are still optimizing for yesterday's definition of satisfaction. The real opportunity isn't adding another functional ingredient. It's recognizing that the relationship between flavor, fullness and reward may be changing.